monoacetyldapsone has been researched along with Duhring Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, RA; Fry, L; Leonard, JN; Rogers, HJ; Swain, AF | 1 |
| Breckenridge, AM; Coleman, MD; Friedmann, PS; Park, BK; Rhodes, LE; Scott, AK; Verbov, JL | 1 |
| Sanders, SW; Zone, JJ | 1 |
3 other study(ies) available for monoacetyldapsone and Duhring Disease
| Article | Year |
|---|---|
Pharmacokinetic observations on dapsone in dermatitis herpetiformis.
Topics: Adult; Aged; Anti-Infective Agents; Dapsone; Dermatitis Herpetiformis; Half-Life; Humans; Intestine, Small; Kinetics; Middle Aged; Protein Binding; Skin | 1983 |
The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
Topics: Adult; Aged; Aged, 80 and over; Cimetidine; Dapsone; Dermatitis Herpetiformis; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Male; Methemoglobinemia; Middle Aged | 1992 |
The relationship between dapsone dose, serum concentration and disease severity in dermatitis herpetiformis.
Topics: Acetylation; Antigen-Antibody Complex; Biological Availability; Dapsone; Dermatitis Herpetiformis; Dietary Proteins; Dose-Response Relationship, Drug; Glutens; Humans; Immunoglobulin A; Phenotype | 1986 |